Interactive graphic explaining how Penn's HIV gene therapy study, the first of its kind which may lead to a cure for HIV. Related: Penn Med develops HIV-resistant immune cells
A possible cure to HIV
·
The Daily Pennsylvanian is an independent, student-run newspaper. Please consider making a donation to support the coverage that shapes the University. Your generosity ensures a future of strong journalism at Penn.
DonateMost Read
-
1
Wharton MBA program falls to third place in 2026 Financial Times ranking By Ana Laura Citalán · Feb. 19, 2026 -
2
Penn graduate worker stipends comparable to peer institutions under tentative pay raise By James Wan · Feb. 17, 2026 -
3
Students press Penn for greater support, clarification over potential ICE presence on campus By Kathryn Ye · Feb. 19, 2026 -
4
Wharton admits inaugural Master of Science degree in quantitative finance class By Moukthikadevi Kanakala · Feb. 18, 2026 -
5
Amid calls for reform, Penn experts discuss effects of private equity funding in health care By Addison Saji · Feb. 17, 2026 -
6
Penn advises international students to carry immigration documents as federal enforcement escalates By Anjali Kumar · Feb. 19, 2026 -
7
Spruce Street, Houston Market close following two water main breaks -
8
New federal funding bill offers ‘stability’ for Penn Medicine research, expands telehealth access By Nora Garg · Feb. 19, 2026 -
9
Penn Carey Law student groups host Immigration Know Your Rights Training By Kori Robinson · Feb. 19, 2026 -
10
The path leading up to GET-UP's tentative agreement with Penn
Penn Connects
